BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Endothelial cell
,
Nosology
,
Trichostatin A
,
rs2300478
,
PPARA
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Erk1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Transverse colon
Ascending colon
Sigmoid colon
Rectum colon
Cecum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
ERK1/2-dependent TSPO overactivation associates with the loss of mitophagy and mitochondrial respira…
The complex impact of cancer-related missense mutations on the stability and on the biophysical and …
Insulin-Like Growth Factor1 Preserves Gastric Pacemaker Cells and Motor Function in Aging via ERK1/2…
PP4R1 promotes glycolysis and gallbladder cancer progression through facilitating ERK1/2 mediated PK…
Taurine promotes insulin synthesis by enhancing Isl-1 expression through miR-7a/RAF1/ERK1/2 pathway.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
Phosphorylation of ERK1/2 in Patients With Parkinson's Disease
Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelo…
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable o…
Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ